z-logo
open-access-imgOpen Access
Late relapse of testicular cancer
Author(s) -
Emre Akar,
Deniz Tural,
Deniz Arslan,
Cumhur İ̇brahim Başsorgun,
Özcan Yıldız
Publication year - 2015
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.137915
Subject(s) - testicular cancer , medicine , oncology , cancer , gynecology
Late relapse of testicular cancer, defined as >2 years interval between initial treatment and recurrence, is a rare disease with the incidence rate of 2.6%. Due to its chemoresistant features, treatment options of late relapses are controversial while surgical approach and cisplatin-based chemotherapies can be considered. We report here a patient with nonseminomatous germ cell tumor who experienced relapse 24 years after his first diagnosis. After detecting left supraclavicular lymphadenopathy and absence of any other malignant lesion in positron emission tomography-computerized tomography, patient was treated with three cycles of VeIP regimen (vinblastine/ifosfamide/cisplatin). Second complete response to this treatment was achieved with chemotherapy alone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here